Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2204-2026

Swan-Ganz Pacing Catheter, Models: D200F7; Recall

Swan-Ganz Pacing Catheter, Models: D200F7;

FDA recall Class II

Ongoing

FDA lists this Class II recall for Swan-Ganz Pacing Catheter, Models: D200F7;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2204-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 8, 2026
FDA report date
May 27, 2026
Quantity in commerce
53
Distribution
See key details
FDA cause
Process change control

What is being recalled?

Swan-Ganz Pacing Catheter, Models: D200F7;

Affected model & UDI checker

Search the exact identifiers published for Z-2204-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
D200F7Swan-Ganz Pacing Catheter, Models: D200F7;Check source noticeNot specified
FDA code information

Model-UDI-DI/Lot(Expiration): D200F7-00690103147315/66725358(7/2/2027)

View the original FDA recall notice

Why was this product recalled?

Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.

What actions did Becton Dickinson and Company take?

On 4/8/2026, mailed correction notices were mailed to customers and distributors who were informed of the following: Consider the following to reduce the potential for hub breakage issues. Minimize manipulation of proximal injectate hub and lumen. Pay frequent attention to the (blue) proximal injectate lumen for leakage or breakage, and exchange with another catheter if the issue is encountered. Modify existing clinical workflows to minimize flexing and stress of (blue) proximal injectate lumen. For example: o Securing the catheter lumens to an IV arm board to mitigate bending/flexing of the lumen(s) o Consider using the stopcock on white hub to allow for intermittent transducer pressure tubing changes without twisting white hub on Swan Ganz (blue) proximal injectate lumen. o Prevent CO-Set syringe and proximal injectate lumen from dangling/hanging without support. o Change to automated cardiac output models to mitigate device stress. Providers and institutions may choose to utilize transthoracic or transesophageal echocardiography in combination with techniques to monitor central venous pressure via a central venous catheter in patients in need of right ventricle monitoring and management. Converting to Acumen IQ / FloTrac sensor can provide continuous minimally invasive hemodynamic monitoring from the arterial line. Consider using ClearSight cuff for continuous non-invasive hemodynamic monitoring. Distributors should forward the correction notice to customers who have purchased the impacted product. Complete and return the acknowledgement form via email to SMB-FCAUSAPM@bd.com Questions can be directed to the firm's Customer Service at (800) 424-3278

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology